Headache & Migraine Archives - Medical Conferences

Occipital nerve stimulation effective and safe in chronic cluster headache

Presented By

Dr Poldi Wilbrink, Zuyderland Medical Centre, the Netherlands

Trial

Phase 3, ICON

Conference

IHC 2021

8 November, 2021 16:30

Robust evidence that cluster headache has a genetic basis

Presented By

Dr Bendik S. Winsvold, Oslo University Hospital, Norway

Conference

IHC 2021

8 November, 2021 15:35

Morphological changes in cluster headache between attacks

Presented By

Dr Kuan-Lin Lai, Taipei Veterans General Hospital, Taiwan

Conference

IHC 2021

8 November, 2021 15:21

Predictors of health-related quality of life in cluster headache

Presented By

Dr Soo-Kyoung Kim, Gyeongsang National University, South Korea

Conference

IHC 2021

8 November, 2021 14:29

IHC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

IHC 2021

30 September, 2021 23:06

Occipital nerve stimulation in drug-resistant cluster headache

Presented By

Dr Javier Membrilla, University Hospital La Paz, Spain

Conference

EAN 2021

18 August, 2021 10:51

Nitroglycerin-induced cluster headache attacks characterised comprehensively

Presented By

Dr Diana Y. Wei, King's College London, UK

Conference

MTIS 2020

27 October, 2020 15:40

Migraine as a cyclical functional disorder

Presented By

Mr Daniele Martinelli, University of Pavia, Italy

Conference

EAN 2020

10 September, 2020 11:07

Reassuring real-world safety profile of 3 CGRP inhibitors

Presented By

Prof. Stephen D. Silberstein, Thomas Jefferson University, PA, USA

Conference

EAN 2020

10 September, 2020 11:03

Long-term cardiovascular safety of erenumab

Presented By

Dr Stewart Tepper, Geisel School of Medicine, USA

Conference

EAN 2020

10 September, 2020 10:58

Real-world data for erenumab in Germany

Presented By

Prof. Andreas Straube, Ludwig-Maximilians-University Munich, Germany

Trial

TELESCOPE

Conference

EAN 2020

9 September, 2020 17:13

Eptinezumab in chronic migraine and medication-overuse headache

Presented By

Prof. Hans-Christoph Diener, Medical Faculty of the University Duisburg-Essen, Germany

Trial

Phase 3, PROMISE-2

Conference

EAN 2020

9 September, 2020 17:09

Fremanezumab tolerability in cardiovascular patients with migraine

Presented By

Dr Gianluca Coppola, Sapienza University of Rome, Italy

Trial

Phase 3, HALO, FOCUS

Conference

EAN 2020

9 September, 2020 17:05

Effects of galcanezumab on health-related quality of life

Presented By

Dr Stewart Tepper, Geisel School of Medicine, USA

Trial

Phase 3, CONQUER

Conference

EAN 2020

9 September, 2020 16:44

Unmet needs and pipeline

Presented By

Prof. Christian Lampl, Headache Medical Center, Austria

Conference

EAN 2020

9 September, 2020 16:39

The role of neurogenic inflammation in migraine

Presented By

Prof. Lars Edvinsson, Lund University, Sweden

Conference

EAN 2019

27 August, 2019 23:09

Atogepant efficacious, safe, and well-tolerated for migraine prevention

Conference

EAN 2019

27 August, 2019 22:11

Short- and long-term efficacy of erenumab in hard-to-treat patients

Trial

LIBERTY, STRIVE

Conference

EAN 2019

27 August, 2019 21:13

Fremanezumab results of the FOCUS study

Trial

Phase 3, FOCUS

Conference

EAN 2019

27 August, 2019 20:15

Galcanezumab reduces healthcare resource utilisation

Trial

Phase 3, REGAIN

Conference

EAN 2019

27 August, 2019 19:17

Lasmiditan in migraine patients with CV risk factors

Trial

Phase 3, SAMURAI and SPARTAN

Conference

EAN 2019

27 August, 2019 18:18

Factors influencing choice of prophylactic migraine therapy

Trial

PANORAMA

Conference

EAN 2019

27 August, 2019 15:19

Atogepant effective and safe for migraine prevention

Conference

AAN 2019

30 July, 2019 23:33

Eptinezumab reduces mean monthly migraine days

Trial

Phase 3, PROMISE

Conference

AAN 2019

30 July, 2019 21:35

Non-invasive vagus nerve stimulation for cluster headache

Conference

AAN 2019

30 July, 2019 09:41

Lessons learned from triptan therapy

Presented By

Dr Patricia Pozo-Rosich & Prof. Rami Burstein

Trial

PREEMPT

Conference

TOXINS 2019

15 March, 2019 23:51

Central and peripheral mechanisms in migraine

Presented By

Prof. Anthony Dickenson, University College London, United Kingdom

Conference

TOXINS 2019

15 March, 2019 22:54

Pain and sensory mechanisms

Presented By

Prof. Cristina Tassorelli, University of Pavia, Italy

Conference

TOXINS 2019

15 March, 2019 21:57

Predictors of response

Presented By

Dr Patricia Pozo-Rosich, Vall d’Hebron University Hospital, Spain

Conference

TOXINS 2019

15 March, 2019 16:00